These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 135384)

  • 21. The early diagnosis of renal allograft rejection in man.
    Carpenter CB
    Adv Nephrol Necker Hosp; 1975; 5():229-56. PubMed ID: 127521
    [No Abstract]   [Full Text] [Related]  

  • 22. Improved renal allograft survival using the mixed lymphocyte culture for selection of nonidentical living related donors.
    Riggio RR; Saal SD; Katz EB; Tapia L; White R; Chami J; Sheigh JS; Sullivan JF; Stenzel KH; Stubenbord WT; Whitsell JC; Rubin AL
    Trans Am Soc Artif Intern Organs; 1975; 21():90-5. PubMed ID: 1096421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of renal transplant recipients using immunologic monitoring.
    Miller J; Kyriakides G; Flaa C
    Transplant Proc; 1979 Mar; 11(1):360-3. PubMed ID: 156425
    [No Abstract]   [Full Text] [Related]  

  • 24. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-dependent cell-mediated cytotoxicity for human monolayer target cells bearing blood group and transplantation antigens and for melanoma cells.
    Kodera Y; Bean MA
    Int J Cancer; 1975 Oct; 16(4):579-92. PubMed ID: 1080751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
    Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
    Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
    Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
    PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blocking versus cytotoxic antibody in HL-A- and mixed lymphocyte culture-identical and nonidentical human renal transplant recipients.
    Miller J; Lifton J; Rood F; Hattler BG
    Transplantation; 1975 Jul; 20(1):53-62. PubMed ID: 126511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection.
    Davenport A; Younie ME; Parsons JE; Klouda PT
    Nephrol Dial Transplant; 1994; 9(9):1315-9. PubMed ID: 7816298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
    Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
    Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection.
    Gupta RK; Jain M; Sharma RK
    Indian J Med Res; 2004 Jan; 119(1):24-7. PubMed ID: 14997990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-donor immune responses in prediction of transplant rejection.
    Stiller CR; StC Sinclair NR; Abrahams S; McGirr D; Singh H; Howson WT; Ulan RA
    N Engl J Med; 1976 Apr; 294(18):978-82. PubMed ID: 130555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement.
    Zhao X; Huang G; Randhawa S; Zeng G; Lunz J; Randhawa P
    Transplantation; 2017 Feb; 101(2):395-401. PubMed ID: 26901079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of lymphocyte-dependent antibody in kidney transplantation.
    Jeannet M; Vassalli P
    Transplantation; 1976 Nov; 22(5):493-9. PubMed ID: 793105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human renal allograft rejection is predicted by serial determinations of antibody-dependent cellular cytotoxicity.
    Dumble LJ; MacDonald IM; Kincaid-Smith P
    Transplantation; 1980; 29(1):30-4. PubMed ID: 6989039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Area under the serum creatinine time-curve is a strong predictor of chronic renal allograft rejection.
    Setterberg L; Elinder CG; Fored CM; Tyden G; Reinholt FP
    Transplantation; 2000 Mar; 69(5):964-8. PubMed ID: 10755558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?
    Frei U; Schindler R; Wieters D; Grouven U; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 1995; 10(7):1206-11. PubMed ID: 7478125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.